Redmile Group’s DexCom DXCM Stock Holding History

Redmile Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-244,391	Closed	-$22.8M	–	71
2023 Q3	$22.8M	Sell	244,391 -44,770	-15%	-$5.05M	1.08%	29
2023 Q2	$37.2M	Sell	289,161 -46,887	-14%	-$5.67M	1.43%	22
2023 Q1	$39M	Buy	+336,048	New	+$37.6M	1.69%	21
2021 Q3	–	Sell	-922,232	Closed	-$98.4M	–	80
2021 Q2	$98.4M	Buy	922,232 +32,400	+4%	+$3.11M	1.46%	23
2021 Q1	$79.9M	Buy	+889,832	New	+$83.5M	1.13%	30
2020 Q4	–	Sell	-333,648	Closed	-$34.4M	–	89
2020 Q3	$34.4M	Sell	333,648 -55,552	-14%	-$5.8M	0.63%	44
2020 Q2	$39.4M	Sell	389,200 -128,000	-25%	-$11.4M	0.73%	41
2020 Q1	$34.8M	Buy	+517,200	New	+$32.2M	0.98%	33
2019 Q4	–	Sell	-1,216,632	Closed	-$45.4M	–	67
2019 Q3	$45.4M	Buy	1,216,632 +528,232	+77%	+$20.5M	1.52%	21
2019 Q2	$25.8M	Buy	+688,400	New	+$21.6M	0.73%	41
2016 Q4	–	Sell	-9,840	Closed	-$216K	–	54
2016 Q3	$216K	Buy	+9,840	New	+$219K	0.02%	47

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Redmile Group's DXCM Position: Q4 2023 in Review

Redmile Group sold out of DexCom (DXCM) in Q4 2023, closing a stake of 244,391 shares — an estimated $22.8M sold.

Redmile Group first reported a position in DXCM in Q3 2016 and held it in 11 quarters. The position peaked at $98.4M in Q2 2021. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Redmile Group reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Redmile Group sold 244,391 DexCom shares in Q4 2023, an estimated $22.8M.
Redmile Group first reported a position in DexCom in Q3 2016 and held it in 11 quarters.
Redmile Group's DexCom position peaked at $98.4M in Q2 2021.
975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Redmile Group's 13F filing for Q4 2023, filed 14 Feb 2024.